Developmental and behavioral consequences of prenatal fluoxetine

Pharmacology

Volumn 79, Issue 1, 2007, Pages 1-11

  Bairy, K L ^a   Madhyastha, S ^b   Ashok, K P ^b   Bairy, Indira ^a   Malini, S ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

^b KASTURBA MEDICAL COLLEGE   (India)

Author keywords

Behavioral tests; Depression; Fluoxetine; Selective serotonin reuptake inhibitor; Teratogenicity

Indexed keywords

FLUOXETINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONGENITAL MALFORMATION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DOSE RESPONSE; DRUG DOSE COMPARISON; FEMALE; FUNCTION TEST; GESTATION PERIOD; LEARNING; LOW BIRTH WEIGHT; MALE; MAZE TEST; MEMORY; MOTOR DEVELOPMENT; NONHUMAN; OPEN FIELD BEHAVIOR; PERINATAL PERIOD; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT; SPONTANEOUS ABORTION; TERATOGENICITY; WEANING;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BIRTH WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; FEMALE; FLUOXETINE; HEAD MOVEMENTS; LITTER SIZE; MAZE LEARNING; MOTOR ACTIVITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; SEROTONIN UPTAKE INHIBITORS; SEX FACTORS; TIME FACTORS; TOOTH ERUPTION;

EID: 33845917359     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096645     Document Type: Article

References (22)

1. Callahan BT, Yuan J, Ricaurte GA: Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine. Synapse 2000;38:471-476.
2. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL: Birth outcomes in pregnant women taking fluoxetine. N Eng J Med 1996;35:1010-1015.
3. Vorhees C, Acuff-Smith K, Schilling M, Fisher J, Moran M, Buelke-Sam JA: Developmental neurotoxicity evaluation of the effects of prenatal exposure to fluoxetine in rats. Fundam Appl Toxicol 1994;23:194-205.
4. Stewart C, Scalzo F, Valentine J, Holson R, Ali S, Slikker W: Gestational exposure to cocaine or pharmacologically related compounds: effects on behavior and striatal dopamine receptors. Life Sci 1998;63:2015-2022.
5. Da-Silva VA, Altenburg SP, Malheiros LR, Thomaz TG, Lindsey CJ: Postnatal development of rats exposed to fluoxetine or venlafaxine during the third week of pregnancy. Braz J Med Biol Res 1999;32:93-98.
6. Addis A, Koren G: Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies. Psychol Med 2000;30:89-94.
7. Janna L, Morrison AD, Wayne Riggs B, Dan W, Rurak C: Fluoxetine during pregnancy: impact on fetal development. Reprod Fert Dev 2005;17:641-650.
8. Nulman I, Korean G: The safety of fluoxetine during pregnancy and lactation. Teratology 1996;53:304-308.
9. Goulart EC, Pereira CAT, Garcia RC, Giacomelli MBO, Rodrigues ALS: Effects of lead and/or zinc exposure during the second stage of rapid postnatal brain growth on delta-aminolevulinate dehydratase and negative geotaxis of suckling rats. Braz J Med Biol Res 2001;34:785-790.
10. Tobach E: Manipulation effects, open field experience and digestive transit time in Wistar male and female rats. Psychol Rep 1996;19:375-378.
11. Bures J, Buresova D: Learning and memory; in Bures J, Buresova, Houstan JP (eds): Techniques and Basic Experiments for the Study of Brain and Behavior. New York, Elsevier, 1983, pp 148-152.
12. Hamm RJ, Pike BR, O'Dell DM, Lyeth BG, Jenkins LW: The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. J Neurotrauma 1994;11:187-196.
13. Morris RGM: Spatial localization does not depend on the presence of local cues. Learn Motiv 1981;12:239-260.
14. Brown RW, Kraemer PJ: Ontogenetic differences in retention of spatial learning tested with Morris water maze. Dev Psychobiol 1997;30:329-341.
15. Varty GB, Morgan CA, Cohen-Williams ME, Coffin VL, Carey GJ: The Gerbil Elevated Plus-Maze I: behavioral characterization and pharmacological validation. Neuropsychopharmacology 2002;27:357-370.
16. Liang KC, Tsui KY, Tyan YM, Chiang TC: Buspirone impaired acquisition and retention in avoidance tasks: involvement of the hippocampus. Chin J Physiol 1998;41:33-44.
17. Azmita EC, Whitaker-Azmita PM: Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic system. J Clin Psychiatry 1991;52:4-14.
18. Jacob EL, Formal CA: Activity of brain serotonergic neurons in the behaving animal. Pharmacol Rev 1991;43:563-578.
19. Gross-Isseroff R, Salama D, Iisraeli M, Biegon A: Autoradiography analysis of age-dependent changes in serotonin 5-HT2 receptor of the human brain postmortem. Brain Res 1990;21:381-399.
20. Vannier B, Saillenfait AM: Methodological proposal in behavioral teratogenicity testing: assessment of propoxyphene, chlorpromazine, and vitamin A as positive controls. Teratology 1988;37:185-199.
21. Vedernikov Y, Bolanos S, Bytautiene E: Effects of fluoxetine on contractile activity of pregnant rat uterine rings. Am J Obstet Gynecol 2002;182:269-279.
22. Tuomsti J, Mannisto P: Neurotransmitter regulation of anterior pituitary hormones. Pharmacol Rev 1985;37:249-332.